NGM Bio Holdings, Inc.

Biotech South San Francisco, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
South San Francisco, CA
Street
611 Gateway Blvd., Suite 540
Zip
94080

Offering

Total offering
$142M
Amount sold
$142M
First sale
Jul 5, 2024
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
26

How this filing compares

Ranked #1 of 23 Biotech filings in March 2026 by offering amount.

Median Biotech filing in March 2026: $5.4M. This offering is 26.2× the median.

Other California filings this week: 137 Holdings ISI, LLC, Am Tech Fund I LP, ARTELO BIOSCIENCES, INC., Be Bold Beverage, Inc., Calia 9 LLC

Leadership

Roger M. Perlmutter — Director

Peter Svennilson — Director

Diana Peng Bockus — Executive Officer (also: Director)

Tim Kutzkey — Director

Filing details

NGM Bio Holdings, Inc. filed a Form D with the SEC on March 27, 2026.

Other newest Biotech companies

Other newest companies in California